Uses of Vitasmooth

Vitasmooth drug works to provide calcium and vitamin D3 for patients with deficiency, especially adolescents, and supports the treatment of osteoporosis, rickets, osteomalacia, strengthens bones, and improves quality. life.

Vitasmooth drug has the main ingredients and effects are:
Calcium carbonate: Provides calcium to the body, regulates the permeability of cell membranes, helps the growth of the body's bone and teeth system. Calcium deficiency occurs when the daily diet does not provide enough calcium, especially in children, adolescents, the elderly, and women before and after menopause. Vitamin D3: Participates in the process of bone formation, increases the absorption of calcium and phosphate into the intestine, plays an important role in the process of calcification of growth cartilage of the body. When the body is deficient in vitamin D3, blood calcium levels are reduced because the intestines cannot absorb calcium, so calcium is mobilized from the bones to stabilize blood calcium levels. As a result, children have rickets, bow legs, slow walking, slow growth and slow fontanelle.

Vitasmooth is indicated for use in the following cases:
The elderly are deficient in vitamin D and calcium. Support in the specific treatment of osteoporosis, rickets, osteomalacia, acute and chronic bone loss, Scheuermann's disease. Patients are at high risk of vitamin D and calcium deficiency such as prolonged use of corticosteroids, long-term immobility after injury, after gastrectomy, ...). Children and adolescents at puberty lack calcium and vitamin D3 for the development of bones and teeth. Prevention and treatment of osteoporosis in pregnant and lactating women. Patients on hemodialysis need calcium supplements.

How to use: Vitasmooth is in the form of chewable tablets. The patient can swallow, suck or chew the tablet. The best time to use is after breakfast or lunch. Do not use Vitasmooth in the evening because it will affect the absorption of the drug.
Dosage: Depending on the level of deficiency, there are different doses of Vitasmooth supplements. Therefore, patients should consult their doctor or pharmacist before using the drug.
Reference dose of Vitasmooth is as follows:
Adults and children over 12 years of age, depending on the need for daily calcium supply: 1 to 2 tablets / day, drink with 1 glass of water after eating. Children under 12 years: No dose studies of Vitasmooth in children under 12 years of age have been performed. When the patient misses a dose: Take that dose as soon as you remember and skip the missed dose if it is almost time for the next dose. Take the next dose as scheduled, do not double the dose already prescribed.

When using Vitasmooth may cause some unwanted effects as follows:
Body and skin: Itching, rash and red rash, calcification of soft tissues, allergic reactions. Digestive system: Digestive disorders, constipation, diarrhea, flatulence, nausea, stomach pain. Circulatory system: Risk of hypercalcaemia, urinary calcium and phosphorus, vitamin D toxicity. Nervous system: Mental changes, confusion, delirium, dystrophy sensory nerve disorders. If the patient notices any side effects, immediately notify a qualified doctor or pharmacist for timely treatment.

VitaSmooth drug is not indicated for the following cases:
Patients with a history of allergy, hypersensitivity to Calcium, vitamin D and any of the ingredients of the drug. Patients with hypercalcemia, urinary calcium, kidney stones. People with medical conditions that lead to hypercalcemia and/or urinary calcium such as osteosarcoma (bone metastases), overactive parathyroid disease, bone marrow disease (myeloma). Patients with severe renal failure. Patients with excess vitamin D (excess vitamin D disorder). Patients with hereditary fructose intolerance, glucose - galactose malabsorption or sucrase - isomaltase deficiency.

Using Vitasmooth drug should be cautious with the following information:
Patients with mild and moderate renal impairment or patients with hypercalcemia should be closely monitored for clinical symptoms. Routine examination of blood calcium and urinary calcium levels in this patient population. In patients with a history of kidney stones, the test measures the extent of renal calcium excretion to avoid hypercalciuria. Patients on prolonged Vitasmooth therapy should have regular monitoring of serum calcium, urinary calcium and renal function. Reduce dose or temporarily discontinue therapy if urinary calcium exceeds 7.5 mmol/day (300 mg/day). People with benign lymphoma granulomatosis or other malignancies are at increased risk of hypercalcemia. It is recommended to drink a lot of water or infusion to increase urine volume to avoid the formation of kidney stones in people with hypercalciuria. Pregnant women: Should use the drug under the direction of the doctor. During pregnancy, calcium and vitamin D requirements increase but can be obtained from other sources. If a pregnant mother has long-term hypercalcemia, it will lead to physical and intellectual retardation, aortic stenosis and retinopathy in the newborn. Therefore, pregnant women should not arbitrarily use the drug to avoid overdose causing unwanted side effects. Lactation: Vitamin D and its metabolites can pass into breast milk, and there are no studies using Vitasmooth in lactating women. Mothers should use the drug under the direction of a doctor. For drivers and operators: The drug has no effect on driving and operating machines

Vitasmooth may interact with some drugs when used concurrently. To ensure safety and effectiveness, patients need to inform their doctor about all medicines, supplements they are taking and other medical conditions they have or are suffering from.
Digitalis: Increased toxicity of Digitalis (risk of arrhythmias). Bisphosphonates, fluoride salts: Due to the risk of reduced gastrointestinal absorption of this drug, it should be taken at least 2 hours before taking Vitasmooth. Thiazide diuretics: Increases urinary calcium, may be toxic to the kidneys. Tetracycline antibiotics: Reduced absorption of tetracyclines should be taken at least 2 hours before or 4-6 hours after taking Vitasmooth chewable tablets. Quinolone antibiotics: Concomitant use of Vitasmooth with some Quinolone antibiotics (eg, Ciprofloxacin) may reduce the bioavailability of Quinolones, should be taken at least 3 hours apart, not at the same time. time. Cardiac Glycosides (such as Digoxin): Increased side effects if too much Vitasmooth is taken. Estramustine (chemotherapy), thyroid hormone, drugs containing iron, zinc: Decrease the amount that the body absorbs. Take these medications at least 2 hours before or after taking Vitasmooth chewable tablets. Orlistat (obesity medicine), laxatives such as Paraffin oil, Cholestyramine: Reduces the amount of vitamin D3 in Vitasmooth that the body absorbs. Corticosteroids: Should not be used concomitantly with Vitasmooth because it reduces calcium absorption from the intestine and interferes with the effects of vitamin D. Vitasmooth should not be used concomitantly with Phenobarbital and/or Phenytoin. Vitasmooth helps to supplement calcium and vitamin D for the body, so it is indicated for supportive treatment of osteoporosis, rickets, osteomalacia, acute and chronic bone loss, helping users to be more healthy, strong bones, full of energy. quantity. To ensure effective use, patients need to read the instructions carefully before use or consult a doctor, professional pharmacist.